Pharmaceutical Enzymes by Albert Lauwers, Simon Scharpe

By Albert Lauwers, Simon Scharpe

This well-integrated, one of a kind source deals finished, interdisciplinary analyses of the total pharmaceutical enzyme field;from molecular biology to scientific pharmacology. Highlights functional, formerly unpublished details, instantly valuable in and educational associations! Emphasizing pharmacology and scientific impression, Pharmaceutical Enzymes discusses strong tools of dimension and assessment studies present wisdom at the bioavailability of pharmaceutical enzymes provides diversified chemical techniques to tailoring enzymes for the advance of healing effectiveness presents a step by step method of molecular modeling describes lately brought pharmaceutical items, together with glucocerebrosidase for the therapy of Gaucher's sickness and deoxyribonuclease for cystic fibrosis furnishes designated laboratory guidance for the checking out and qc of pharmaceutical enzymes and extra! With over 1200 bibliographic citations, figures, and tables, Pharmaceutical Enzymes is an crucial, daily reference for pharmacologists, enzymologists, microbiologists, natural and medicinal chemists and biochemists, biophysicists, biotechnologists, molecular and membrane biologists, immunologists, physiologists, pharmaceutical improvement managers, regulatory affairs team of workers, and graduate-level scholars in those disciplines.

Show description

Read Online or Download Pharmaceutical Enzymes PDF

Similar pharmacology books

Extra info for Pharmaceutical Enzymes

Sample text

89: 11322–11326. 28. Jain, A. , Dietterich, T. , Lathrop, R. , Critchlow, R. , Bauer, B. , Webster, T. A. & Lozanoperez, T. (1994). Compass – a shape-based machine learning tool for drug design. J Comput Aided Mol Des. 8: 635–652. 29. Zheng, W. F. & Tropsha, A. (2000). Novel variable selection quantitative structure-property relationship approach based on the k-nearestneighbor principle. J Chem Inf Comput Sci. 40: 185–194. 30. Xue, C. , Zhang, R. , Liu, H. , Yao, X. , Liu, M. , Hu, Z. D. & Fan, B.

If the target structures are known, structure-based approaches can be used such as molecular docking, which employs the target 3D structures to design novel active compounds with improved potency. As more structures are becoming available, the prediction accuracy will likely to be improved. 1. Ligand-Based Drug Design In the absence of the receptor 3D information, lead identification and optimization depend on available pharmacologically relevant agents and their bioactivities (5–8). The computational approaches include QSAR, pharmacophore modeling, and database mining (8–10).

3: 15–20. 53. Maryanoff, B. E. (2004). Inhibitors of serine proteases as potential therapeutic agents: The road from thrombin to tryptase to cathepsin G. J Med Chem. 47: 769–787. 54. Chen, L. , Nowak, B. , Ayres, M. , Krett, N. , Rosen, S. , Zhang, S. & Gandhi, V. (2009). Inhibition of ATP synthase by chlorinated adenosine analogue. Biochem Pharmacol. 78: 583–591. 55. , Mash, E. , Meuillet, E. J. & Zhang, S. (2009). Computational modeling of novel inhibitors targeting the Akt pleckstrin homology domain.

Download PDF sample

Rated 4.97 of 5 – based on 20 votes